E-LIB Suche - Ergebnisse für: Wray, Sibyl

1

Lymphopenia is Not the Primary Therapeutic Mechanism of Dir..:

Singer, Barry A. ; Wray, Sibyl ; Gudesblatt, Mark...
Neurology and Therapy. , 2024

2

Safety and clinical effectiveness of peginterferon beta-1a ..:

Salvetti, Marco ; Wray, Sibyl ; Nelles, Gereon...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 10 (2024) 2 - p. , 2024

Link: https://doi.org/10.1177/..

3

Matching-Adjusted Indirect Comparisons of Diroximel Fumarat..:

Jiang, Tammy ; Ziemssen, Tjalf ; Wray, Sibyl...
CNS Drugs. 37 (2023) 5 - p. 441-452 , 2023

Link: https://doi.org/10.1007/..

4

Efficacy of Early Ofatumumab vs Late Switch From Teriflunom..:

Wiendl, Heinz ; Cohen, Jeffrey ; Gold, Ralf...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

5

Diroximel fumarate in patients with relapsing–remitting mul..:

Singer, Barry A ; Arnold, Douglas L ; Drulovic, Jelena...
Multiple Sclerosis Journal. 29 (2023) 14 - p. 1795-1807 , 2023

Link: https://doi.org/10.1177/..

6

Ublituximab Efficacy in Treatment-Naive Participants With R..:

Steinman, Lawrence ; Fox, Edward ; Hartung, Hans-Peter...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

7

Disease Outcomes With Ublituximab in Participants With High..:

Alvarez, Enrique ; Steinman, Lawrence ; Hartung, Hans-Peter...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

8

Ublituximab Treatment Is Associated With a Significant Prop..:

Alvarez, Enrique ; Steinman, Lawrence ; Fox, Edward...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

9

Efficacy and Safety Outcomes with Diroximel Fumarate After ..:

Wray, Sibyl ; Then Bergh, Florian ; Wundes, Annette...
Advances in Therapy. 39 (2022) 4 - p. 1810-1831 , 2022

Link: https://doi.org/10.1007/..

10

Diroximel Fumarate in Patients with Relapsing-Remitting Mul..:

Wray, Sibyl ; Singer, Barry A. ; Drulovic, Jelena...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

11

Infusion-Related Reactions (IRRs) With Ublituximab in Patie..:

Fox, Edward ; Steinman, Lawrence ; Hartung, Hans-Peter...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

12

Relapse Rate and Time to First Relapse Were Improved With U..:

Steinman, Lawrence ; Fox, Edward ; Hartung, Hans-Peter...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

13

Satisfaction with alemtuzumab in relapsing multiple scleros..:

Wray, Sibyl ; Jacques, Francois ; Miller, Tamara A...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8 (2022) 4 - p. 205521732211358 , 2022

Link: https://doi.org/10.1177/..

14

Disability Improvements With Ublituximab in Relapsing Multi..:

Cree, Bruce ; Fox, Edward ; Hartung, Hans-Peter...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

15

Safety and clinical effectiveness of peginterferon beta-1a ..:

Salvetti, Marco ; Wray, Sibyl ; Nelles, Gereon...
Multiple Sclerosis and Related Disorders. 57 (2022) - p. 103350 , 2022

Link: https://doi.org/10.1016/..